Publication 2/18/2021 Long-term stable reduction of low-density lipoprotein in nonhuman primates following in vivo genome editing of PCSK9. Wang L, Breton C, Warzecha CC, Bell P, Yan H, He Z, White J, Zhu Y, Li M, Buza EL, Jantz D, Wilson JM Molecular Therapy : The Journal Of The American Society Of Gene Therapy
Publication 7/09/2018 Meganuclease targeting of PCSK9 in macaque liver leads to stable reduction in serum cholesterol. Wang L, Smith J, Breton C, Clark P, Zhang J, Ying L, Che Y, Lape J, Bell P, Calcedo R, Buza EL, Saveliev A, Bartsevich VV, He Z, White J, Li M, Jantz D, Wilson JM Nature Biotechnology
